Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
pemetrexed
.
Show all posts
Showing posts with label
pemetrexed
.
Show all posts
Thursday, February 16, 2017
Novel combination therapy shows strong response in phase 1 trial
›
In continuation of my update on Sorafenib , Premetrexed , Vandetanib "Though phase 1 studies are designed to evaluate the safety ...
Wednesday, January 6, 2016
Lilly, Merck expand oncology clinical trial collaboration
›
Eli Lilly and Company (NYSE: LLY) and Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the exten...
Tuesday, April 15, 2014
Adult cancer drugs show promise against an aggressive childhood brain tumor
›
Researchers relied on mice with group 3 medulloblastoma grown from patient tumors. The mice were developed in Roussel’s laboratory and are...
›
Home
View web version